Herpes Management and Prevention

Isolation Requirements

• The American Academy of Pediatrics recommends isolation for 3-8 days during primary outbreaks of herpes gladiatorum and herpes rugbiorum, with suspension of competition until lesions are fully crusted 1, 2
• Athletes with active herpes lesions should be excluded from competition until all lesions are fully crusted or until a physician provides written documentation that the condition is non-infectious 1
• For genital herpes, patients should abstain from sexual activity when lesions or prodromal symptoms are present to prevent transmission, as recommended by the Centers for Disease Control and Prevention 3
• Herpes can be transmitted even during asymptomatic periods through viral shedding, requiring ongoing precautions beyond visible outbreaks, according to the Centers for Disease Control and Prevention 3

Diagnostic Confirmation

• Diagnosis involves clinical recognition combined with laboratory confirmation through cell culture, histologic examination, or rapid diagnostic tests such as direct fluorescent antibody staining, enzyme immunoassay, or polymerase chain reaction (PCR), as stated by the American Academy of Pediatrics and the European Centre for Disease Prevention and Control 1, 4
• PCR testing has been shown to be 11-71% more sensitive than viral culture for detecting HSV in genital ulcers, according to the European Centre for Disease Prevention and Control 5
• Type-specific testing can differentiate between HSV-1 and HSV-2, which has prognostic importance as HSV-1 tends to cause fewer recurrences than HSV-2, as recommended by the Centers for Disease Control and Prevention 3

Treatment During Isolation Period

• Valacyclovir (500 mg daily or twice daily for 7 days) given within 24 hours of symptom onset can shorten the duration of HSV PCR clearance from lesions by 21% (from 8.1 days with placebo to 6.4 days with valacyclovir), as stated by the American Academy of Pediatrics 1
• First-line treatments for active herpes outbreaks include acyclovir 400 mg orally three times daily for 7-10 days, acyclovir 200 mg orally five times daily for 7-10 days, famciclovir 250 mg orally three times daily for 7-10 days, and valacyclovir 1 g orally twice daily for 7-10 days, as recommended by the Centers for Disease Control and Prevention 3

Criteria for Ending Isolation

• Athletes may return to competition when all lesions are fully crusted, as stated by the American Academy of Pediatrics 1, 2
• Alternatively, a physician's written statement indicating the condition is non-infectious can allow return to activities, according to the American Academy of Pediatrics 1

Prevention Strategies

• For athletes with history of recurrent herpes infections, suppressive antiviral therapy should be considered, as recommended by the American Academy of Pediatrics 1
• Cleaning of wrestling mats with freshly prepared bleach solution (1 quarter cup of bleach in 1 gallon of water) for a minimum contact time of 15 seconds at least daily and preferably between matches, as stated by the American Academy of Pediatrics 1
• Regular examination of athletes for vesicular or ulcerative lesions before practice or competition, as recommended by the American Academy of Pediatrics 1
• For genital herpes, condom use is recommended during all sexual exposures with new or uninfected partners, according to the Centers for Disease Control and Prevention 3

Special Considerations

• Immunocompromised patients, including those with HIV, may experience more severe herpes infections requiring longer treatment courses, as stated by the American College of Physicians 6

Common Pitfalls

• Failure to recognize that herpes can be transmitted even during asymptomatic periods through viral shedding, as warned by the Centers for Disease Control and Prevention 3
• Delayed initiation of antiviral therapy, which is most effective when started within 24 hours of symptom onset, according to the American Academy of Pediatrics and the Centers for Disease Control and Prevention 1, 3

Prophylaxis and Return‑to‑Competition Guidelines for Herpes Gladiatorum in Wrestlers

Prophylactic Suppressive Therapy

• The pediatric guideline recommends seasonal suppressive antiviral therapy (valacyclovir 500 mg once daily) for athletes with a history of recurrent herpes gladiatorum to reduce outbreak frequency and asymptomatic viral shedding. 7

Return‑to‑Competition Criteria

Primary HSV Infection

• Wrestlers may resume competition only after all systemic symptoms (e.g., fever, malaise) have completely resolved. 8
• No new lesions must have appeared for at least 72 hours before clinical evaluation. 8
• All existing lesions must be fully dry and covered by firm, adherent crusts (no moist lesions). 9
• A minimum of five days of systemic antiviral therapy must be completed before return. 8

Recurrent HSV Infection

• Lesions must be completely dry with firm, adherent crusts before the athlete is cleared to compete. 8
• At least five days of systemic antiviral therapy must be finished prior to return. 8
• Covering active lesions with dressings or bandages is prohibited; lesions must be uncovered and fully crusted. 9

Common Pitfalls to Avoid

• Covered active lesions – Major athletic organizations (e.g., NCAA, NFHS, NATA) prohibit competing with covered active lesions; athletes must be excluded until lesions are fully crusted. [7][8]9
• Topical acyclovir monotherapy – Using topical acyclovir alone is substantially less effective than oral antivirals and should be avoided. 10
• Failure to provide prophylaxis – Omitting seasonal suppressive therapy in athletes with recurrent disease increases the risk of team‑wide outbreaks. 7